Information Library
Results for: Brochures
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Fact Sheet
February 3, 2012
Vacancy Management -
Cardiac Safety Solutions
January 17, 2012
Learn how you can proactively assess and manage cardiac safety issues for your entire product development process with the help of our cardiovascular experts and core ECG laboratory providing validated methodology, sophisticated technology and reliable data. -
Quintiles Infosario Clinical Trial Management System Fact Sheet
January 17, 2012
A fully hosted, global Clinical Trial Management System(CTMS) that provides scalable functionality across multiple business processes. A key component of our Systems as a Service offering, the Quintiles Infosario CTMS provides a centralized location for capturing, viewing, and sharing clinical trial data—from site identification to study closeout. -
Quintiles Infosario Lifecycle Safety System Fact Sheet
December 21, 2011
A comprehensive, cloud-based safety management system that increases customers agility and maximizes cost efficiency. A system designed to manage all safety activities across all programs, -
Sustainable Compliance Begins with a Strong Foundation
December 8, 2011
The urgency of a problem often entices people to quickly focus on finding a solution and repairing the problem in order to immediately remedy the situation. -
Tomorrow's Vision. Today's Reality.
November 23, 2011
The growing impact of real-world and late phase (Phase IIIB/IV) research. -
Quintiles Commercial Solutions
November 21, 2011
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
Whitepaper Using Real Time Data to Drive Better Decisions, Faster
November 21, 2011
Using Real-Time Data to Drive Better Decisions, Faster -
Whitepaper
November 18, 2011
A Blueprint for Clinical/Commercial Convergence:  Constructing a New Development Model with Market Access Insights -
Re-ignite Product Development and Sales with Data Insights: Fueling Innovation Fact Sheet
November 17, 2011
What Will Drive Biopharma’s Future? The long-dreaded crisis is staring us all in the face: What will take the place of expiring blockbusters with few prospects in hand? Spending on R&D more than doubled after 2002, but the output doesn’t match the investment. The number of new molecular entities has remained a disappointment, averaging only around 20 per year in the US. The big question is how can drug developers carve out a strategic path to innovation?
